Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Notes Payables: 2020

Historic Notes Payables for Capricor Therapeutics (CAPR) over the last 1 years, with Dec 2020 value amounting to $246,689.

  • Capricor Therapeutics' Notes Payables was N/A to $282,691 in Q1 2021 from the same period last year, while for Mar 2021 it was $282,691, marking a year-over-year change of. This contributed to the annual value of $246,689 for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Capricor Therapeutics' Notes Payables is $246,689.
  • In the past 5 years, Capricor Therapeutics' Notes Payables ranged from a high of $246,689 in FY2020 and a low of $246,689 during FY2020.
  • Moreover, its 1-year median value for Notes Payables was $246,689 (2020), whereas its average is $246,689.